Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/25/1997 | EP0780469A1 Immortalized human skin cell lines and serum-free medium for the production thereof |
06/25/1997 | EP0780468A1 Transformant producing substance pf1022 and method for transforming microorganism belonging to the class hyphomycetes |
06/25/1997 | EP0779935A1 Detection of hypermutable nucleic acid sequence in tissue |
06/25/1997 | EP0779934A1 Compositions and methods for use in detection of analytes |
06/25/1997 | EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
06/25/1997 | EP0779931A1 Methods for calcium phosphate transfection |
06/25/1997 | EP0779930A1 Methods and compositions for inhibiting production of replication competent virus |
06/25/1997 | EP0779929A1 Non self-inactivating, expression targeted retroviral vectors |
06/25/1997 | EP0779928A1 Acetohydroacid synthase promoter for expression of introduced genes in plants |
06/25/1997 | EP0779927A1 A method of improved production of insulin-like growth factor |
06/25/1997 | EP0779926A1 Transgenic plants expressing acc oxidase genes |
06/25/1997 | EP0779925A2 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe |
06/25/1997 | EP0779924A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
06/25/1997 | EP0779922A2 Modified human c3 proteins |
06/25/1997 | EP0779921A1 CLONED SstI/SacI RESTRICTION-MODIFICATION SYSTEM |
06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
06/25/1997 | EP0779896A1 New process for the production of biologically active protein |
06/25/1997 | EP0779893A2 Oligonucleotide prodrugs |
06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
06/25/1997 | EP0755261A4 Bandage for continuous application of biologicals |
06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
06/25/1997 | EP0623145B1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications |
06/25/1997 | CN1152946A Producing copies of nucleic acids |
06/25/1997 | CN1152942A N-terminally extended proteins expressed in yeast |
06/25/1997 | CN1152941A Genes for the synthesis of antipathogenic substances |
06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
06/25/1997 | CN1152938A Growth control for cells encapsulated within bioartificial organs |
06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
06/25/1997 | CN1152936A Granular formulation containing microorganisms, a process for the preparation and the use thereof |
06/25/1997 | CN1152935A Papillomavirus vaccines |
06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |
06/25/1997 | CN1152924A Proteins from mammaliam liver and their use in oncology |
06/25/1997 | CN1152879A Conjugates made of metal complexes and oligonucleotides |
06/25/1997 | CN1152877A Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
06/25/1997 | CN1152613A Method and device for separating phenotype correlation gene |
06/25/1997 | CN1035257C Midified plutelet factor-4 |
06/24/1997 | US5642035 Transfection high-voltage controller |
06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
06/24/1997 | US5641870 Low pH hydrophobic interaction chromatography for antibody purification |
06/24/1997 | US5641869 Fractionation on immunoaffinity or ion exchange column, ethanol or ammonium sulfate precipitation, reverse phase liquid chromatography, chromatography on silica or heparin sepharose, chromatofocusing, gel filtration, electrophoresis |
06/24/1997 | US5641867 Antitumor agents |
06/24/1997 | US5641866 Bcl-2-associated proteins |
06/24/1997 | US5641864 Kits for high temperature reverse transcription of RNA |
06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
06/24/1997 | US5641860 A glycoprotein useful in the diagnosis of t-lymphoblastic lymphoma and leukemia |
06/24/1997 | US5641837 Method of detecting collagen degradation in vivo |
06/24/1997 | US5641760 Method of treating candida infection |
06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
06/24/1997 | US5641754 Antitumor agents |
06/24/1997 | US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
06/24/1997 | US5641687 Contacting body fluid with immunological binding partner which binds to specified crosslinked collagen telopeptide, detecting binding, correlating with collagen degradation |
06/24/1997 | US5641680 For gene therapy treatment |
06/24/1997 | US5641676 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells |
06/24/1997 | US5641675 Inhibiting intracellular localization of target mrna molecule to periphery of cell in vitro by introducing antisense nucleotide complementary to zipcode region of molecule |
06/24/1997 | US5641674 Nucleotide sequences and proteins conferring cycloheximide resistance |
06/24/1997 | US5641673 Polynucleotide molecule encoding trans-splicing ribozyme with rna sequence hybridizing to target rna encoding transcription activator protein fused to sequence to be trans-spliced into target rna, linked to transcription regulator |
06/24/1997 | US5641672 Nucleic acid molecule; vectors; plasmids; host vector system |
06/24/1997 | US5641671 Includes lipase-specific stabilization/translocation protein |
06/24/1997 | US5641670 Protein production and protein delivery |
06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
06/24/1997 | US5641668 Proteins having glycosyltransferase activity |
06/24/1997 | US5641666 Soraphen A resistant fungi and acetyl-CoA carboxylase |
06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
06/24/1997 | US5641664 Wounding or degrading type i callus and transferring dna into nuclear genome of corn cell |
06/24/1997 | US5641663 Regulatory polynucleotide comprising linked promoter and signal polynucleotides operatively linked to polynucleotide encoding eukaryotic protein |
06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
06/24/1997 | US5641661 Pichia pastoris alcohol oxidase ZZA1 and ZZA2 regulatory regions for heterologous gene expression |
06/24/1997 | US5641660 Glutamicum threonine biosynthetic pathway |
06/24/1997 | US5641658 Method for performing amplification of nucleic acid with two primers bound to a single solid support |
06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
06/24/1997 | US5641656 Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them |
06/24/1997 | US5641655 Genetic engineered dna encoding a protein fusion |
06/24/1997 | US5641654 Medical diagnosis; accuracy |
06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
06/24/1997 | US5641651 Synthetic herpes simplex virus promoters |
06/24/1997 | US5641650 Expression of heterologous polypeptides in halobacteria |
06/24/1997 | US5641649 Expression of osteogenic factor OP-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
06/24/1997 | US5641648 Dna sequences coding for the expression of the large polypeptides; genetic engineering |
06/24/1997 | US5641646 Purification of fused protein and human glicentin is carried out by utilizing a reversible covalent bond of a cysteine residue with the stationary phase of a chromatography column |
06/24/1997 | US5641638 Monoclonal antibodies against Mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof |
06/24/1997 | US5641633 Fluorescence polarization detection of nucleic acids |
06/24/1997 | US5641629 Spectroscopically detectable nucleic acid ligands |
06/24/1997 | US5641627 Measuring expression level of reporter gene when mycotic cells are treated with potential translation(genetic) inhibitors |
06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
06/24/1997 | US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof |
06/24/1997 | US5641490 Recombinant avipox virus comprising exogenous dna from infectious bursal disease virus inserted into nonessential region of avipox virus genome, which expresses structural protein coded for by said exogenous dna |
06/24/1997 | US5641487 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
06/24/1997 | US5641459 Machine for synthesizing oligonucleotides |
06/24/1997 | US5640804 Pest trap plants and crop protection |
06/21/1997 | CA2191903A1 Stress proteins |
06/20/1997 | CA2193315A1 Human mucin (muc8) |
06/19/1997 | WO1997022004A1 Assays for growth hormone secretagogue receptors |
06/19/1997 | WO1997021837A1 Methods for the detection and removal of mutant sequences that arise during enzymatic amplification using mismatch repair systems |
06/19/1997 | WO1997021836A1 Molecular sequence of swine retrovirus and methods of use |
06/19/1997 | WO1997021829A1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |